1

2

Shengyu

Chemical

Dedicated to forging a world-competitive dye and medicine brand

Zhejiang Shengyu Chemical Co., Ltd.

Established in 2005, Zhejiang Shengyu Chemical Co., Ltd. is located in Room 1308, Ocean Plaza, Jiaojiang District, Taizhou City, Zhejiang Province. The company is mainly engaged in R&D, production and sales of dye, dye intermediates, APIs and pharmaceutical intermediates. In recent years, the company has made great efforts to forge a professional high-quality talent team and provide customers with more diversified customized development, production and synthesis businesses.

We use color to make your imagination more diversified

PRODUCTS

CENTER

Specialized in R&D and production of dye, dye intermediates, APIs and pharmaceutical intermediates

Dye series

Dedicated to forging a world-competitive dye brand

Learn more +

Dye intermediates series

Dedicated to forging a world-competitive dye brand

Learn more +

Pharmaceutical APIs series

Dedicated to forging a world-competitive medicine brand

Learn more +

Pharmaceutical intermediates series

Dedicated to forging a world-competitive medicine brand

Learn more +

R & D Center

The company has made great efforts to forge a professional high-quality talent team and provide customers with more diversified customized development, production and synthesis businesses

Learn more +

quality system

The company has made great efforts to forge a professional high-quality talent team and provide customers with more diversified customized development, production and synthesis businesses

Learn more +

News

information

Track information, focus on news

2022-06-02

What is the difference between an API and a finished drug?

Now, many API companies have started or are preparing to transform and upgrade to make preparations. However, the difference between the two is not as far as outsiders see it, they are just medicines.

Learn more +

2022-06-02

The development prospect of China's APIs?

1. The global pharmaceutical market is expected to maintain a growth rate of more than 8% in 2014, the new pharmaceutical market is likely to maintain a greater growth rate, and the domestic market demand for APIs will continue to grow.

Learn more +